 | • レポートコード：D005-11959 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチド及び抗凝固薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチド及び抗凝固薬の種類別市場規模（ホルモン剤、抗生物質、ACE阻害剤、抗真菌剤、その他）、用途別市場規模（糖尿病、感染症、がん、骨粗しょう症、循環器、婦人科、その他の用途）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Celsus、Sun Pharmaceutical Industries、Biofer、Baxter、Bachem、Hemmo Pharma、Abbott Laboratories、AmbioPharm、Wockhardt、Pfizer、Sanofi、Leo Pharma、Eli Lilly、Teva、Aspen、Novo Nordisk、Takeda ・地域別グローバル市場分析 2015年-2020年 ・ペプチド及び抗凝固薬の北米市場（アメリカ、カナダ、メキシコ） ・ペプチド及び抗凝固薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチド及び抗凝固薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチド及び抗凝固薬の南米市場（ブラジル、アルゼンチン） ・ペプチド及び抗凝固薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ホルモン剤、抗生物質、ACE阻害剤、抗真菌剤、その他 ・用途別分析：糖尿病、感染症、がん、骨粗しょう症、循環器、婦人科、その他の用途 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Peptide and Anticoagulant Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 652.8 million by 2025, from USD 477.3 million in 2019.
The Peptide and Anticoagulant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Peptide and Anticoagulant Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptide and Anticoagulant Drugs market has been segmented into
Hormonal
Antibiotic
ACE Inhibitor
Antifungal
Others
By Application, Peptide and Anticoagulant Drugs has been segmented into:
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Cardiology
Gynecology
Other Applications
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptide and Anticoagulant Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptide and Anticoagulant Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptide and Anticoagulant Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Peptide and Anticoagulant Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptide and Anticoagulant Drugs Market Share Analysis
Peptide and Anticoagulant Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptide and Anticoagulant Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptide and Anticoagulant Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Peptide and Anticoagulant Drugs are:
Celsus
Sun Pharmaceutical Industries
Biofer
Baxter
Bachem
Hemmo Pharma
Abbott Laboratories
AmbioPharm
Wockhardt
Pfizer
Sanofi
Leo Pharma
Eli Lilly
Teva
Aspen
Novo Nordisk
Takeda
Among other players domestic and global, Peptide and Anticoagulant Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide and Anticoagulant Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptide and Anticoagulant Drugs, with price, sales, revenue and global market share of Peptide and Anticoagulant Drugs in 2018 and 2019.
Chapter 3, the Peptide and Anticoagulant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide and Anticoagulant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Peptide and Anticoagulant Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Peptide and Anticoagulant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Peptide and Anticoagulant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptide and Anticoagulant Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hormonal
1.2.3 Antibiotic
1.2.4 ACE Inhibitor
1.2.5 Antifungal
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptide and Anticoagulant Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.3.6 Cardiology
1.3.7 Gynecology
1.3.8 Other Applications
1.4 Overview of Global Peptide and Anticoagulant Drugs Market
1.4.1 Global Peptide and Anticoagulant Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Celsus
2.1.1 Celsus Details
2.1.2 Celsus Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Celsus SWOT Analysis
2.1.4 Celsus Product and Services
2.1.5 Celsus Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical Industries
2.2.1 Sun Pharmaceutical Industries Details
2.2.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sun Pharmaceutical Industries SWOT Analysis
2.2.4 Sun Pharmaceutical Industries Product and Services
2.2.5 Sun Pharmaceutical Industries Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biofer
2.3.1 Biofer Details
2.3.2 Biofer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biofer SWOT Analysis
2.3.4 Biofer Product and Services
2.3.5 Biofer Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Baxter SWOT Analysis
2.4.4 Baxter Product and Services
2.4.5 Baxter Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bachem
2.5.1 Bachem Details
2.5.2 Bachem Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bachem SWOT Analysis
2.5.4 Bachem Product and Services
2.5.5 Bachem Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hemmo Pharma
2.6.1 Hemmo Pharma Details
2.6.2 Hemmo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hemmo Pharma SWOT Analysis
2.6.4 Hemmo Pharma Product and Services
2.6.5 Hemmo Pharma Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Abbott Laboratories
2.7.1 Abbott Laboratories Details
2.7.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Abbott Laboratories SWOT Analysis
2.7.4 Abbott Laboratories Product and Services
2.7.5 Abbott Laboratories Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AmbioPharm
2.8.1 AmbioPharm Details
2.8.2 AmbioPharm Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AmbioPharm SWOT Analysis
2.8.4 AmbioPharm Product and Services
2.8.5 AmbioPharm Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Wockhardt SWOT Analysis
2.9.4 Wockhardt Product and Services
2.9.5 Wockhardt Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sanofi SWOT Analysis
2.11.4 Sanofi Product and Services
2.11.5 Sanofi Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Leo Pharma
2.12.1 Leo Pharma Details
2.12.2 Leo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Leo Pharma SWOT Analysis
2.12.4 Leo Pharma Product and Services
2.12.5 Leo Pharma Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Eli Lilly
2.13.1 Eli Lilly Details
2.13.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Eli Lilly SWOT Analysis
2.13.4 Eli Lilly Product and Services
2.13.5 Eli Lilly Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Teva SWOT Analysis
2.14.4 Teva Product and Services
2.14.5 Teva Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Aspen
2.15.1 Aspen Details
2.15.2 Aspen Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Aspen SWOT Analysis
2.15.4 Aspen Product and Services
2.15.5 Aspen Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Novo Nordisk
2.16.1 Novo Nordisk Details
2.16.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Novo Nordisk SWOT Analysis
2.16.4 Novo Nordisk Product and Services
2.16.5 Novo Nordisk Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Takeda
2.17.1 Takeda Details
2.17.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Takeda SWOT Analysis
2.17.4 Takeda Product and Services
2.17.5 Takeda Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Peptide and Anticoagulant Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Peptide and Anticoagulant Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptide and Anticoagulant Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Peptide and Anticoagulant Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Peptide and Anticoagulant Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Peptide and Anticoagulant Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.5 South America Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Peptide and Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Peptide and Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Peptide and Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Peptide and Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.3 UK Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.4 France Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Peptide and Anticoagulant Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Peptide and Anticoagulant Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.5 India Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Peptide and Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Peptide and Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Peptide and Anticoagulant Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Peptide and Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Peptide and Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Peptide and Anticoagulant Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Peptide and Anticoagulant Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Peptide and Anticoagulant Drugs Price by Type (2015-2020)
11 Global Peptide and Anticoagulant Drugs Market Segment by Application
11.1 Global Peptide and Anticoagulant Drugs Sales Market Share by Application (2015-2020)
11.2 Global Peptide and Anticoagulant Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Peptide and Anticoagulant Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Peptide and Anticoagulant Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Peptide and Anticoagulant Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Peptide and Anticoagulant Drugs Market Forecast (2021-2025)
12.2.2 Europe Peptide and Anticoagulant Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Peptide and Anticoagulant Drugs Market Forecast (2021-2025)
12.2.4 South America Peptide and Anticoagulant Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Peptide and Anticoagulant Drugs Market Forecast (2021-2025)
12.3 Peptide and Anticoagulant Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Peptide and Anticoagulant Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Peptide and Anticoagulant Drugs Market Share Forecast by Type (2021-2025)
12.4 Peptide and Anticoagulant Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Peptide and Anticoagulant Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Peptide and Anticoagulant Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Peptide and Anticoagulant Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptide and Anticoagulant Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptide and Anticoagulant Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Celsus Basic Information, Manufacturing Base and Competitors
Table 8. Celsus Peptide and Anticoagulant Drugs Major Business
Table 9. Celsus Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Celsus SWOT Analysis
Table 11. Celsus Peptide and Anticoagulant Drugs Product and Services
Table 12. Celsus Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceutical Industries Peptide and Anticoagulant Drugs Major Business
Table 15. Sun Pharmaceutical Industries Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sun Pharmaceutical Industries SWOT Analysis
Table 17. Sun Pharmaceutical Industries Peptide and Anticoagulant Drugs Product and Services
Table 18. Sun Pharmaceutical Industries Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biofer Basic Information, Manufacturing Base and Competitors
Table 20. Biofer Peptide and Anticoagulant Drugs Major Business
Table 21. Biofer Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Biofer SWOT Analysis
Table 23. Biofer Peptide and Anticoagulant Drugs Product and Services
Table 24. Biofer Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Baxter Basic Information, Manufacturing Base and Competitors
Table 26. Baxter Peptide and Anticoagulant Drugs Major Business
Table 27. Baxter Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Baxter SWOT Analysis
Table 29. Baxter Peptide and Anticoagulant Drugs Product and Services
Table 30. Baxter Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bachem Basic Information, Manufacturing Base and Competitors
Table 32. Bachem Peptide and Anticoagulant Drugs Major Business
Table 33. Bachem Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Bachem SWOT Analysis
Table 35. Bachem Peptide and Anticoagulant Drugs Product and Services
Table 36. Bachem Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Hemmo Pharma Basic Information, Manufacturing Base and Competitors
Table 38. Hemmo Pharma Peptide and Anticoagulant Drugs Major Business
Table 39. Hemmo Pharma Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Hemmo Pharma SWOT Analysis
Table 41. Hemmo Pharma Peptide and Anticoagulant Drugs Product and Services
Table 42. Hemmo Pharma Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Laboratories Peptide and Anticoagulant Drugs Major Business
Table 45. Abbott Laboratories Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Abbott Laboratories SWOT Analysis
Table 47. Abbott Laboratories Peptide and Anticoagulant Drugs Product and Services
Table 48. Abbott Laboratories Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AmbioPharm Basic Information, Manufacturing Base and Competitors
Table 50. AmbioPharm Peptide and Anticoagulant Drugs Major Business
Table 51. AmbioPharm Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 52. AmbioPharm SWOT Analysis
Table 53. AmbioPharm Peptide and Anticoagulant Drugs Product and Services
Table 54. AmbioPharm Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 56. Wockhardt Peptide and Anticoagulant Drugs Major Business
Table 57. Wockhardt Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Wockhardt SWOT Analysis
Table 59. Wockhardt Peptide and Anticoagulant Drugs Product and Services
Table 60. Wockhardt Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Peptide and Anticoagulant Drugs Major Business
Table 63. Pfizer Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Pfizer SWOT Analysis
Table 65. Pfizer Peptide and Anticoagulant Drugs Product and Services
Table 66. Pfizer Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Peptide and Anticoagulant Drugs Major Business
Table 69. Sanofi Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Sanofi SWOT Analysis
Table 71. Sanofi Peptide and Anticoagulant Drugs Product and Services
Table 72. Sanofi Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Leo Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Leo Pharma Peptide and Anticoagulant Drugs Major Business
Table 75. Leo Pharma Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Leo Pharma SWOT Analysis
Table 77. Leo Pharma Peptide and Anticoagulant Drugs Product and Services
Table 78. Leo Pharma Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 80. Eli Lilly Peptide and Anticoagulant Drugs Major Business
Table 81. Eli Lilly Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Eli Lilly SWOT Analysis
Table 83. Eli Lilly Peptide and Anticoagulant Drugs Product and Services
Table 84. Eli Lilly Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Teva Basic Information, Manufacturing Base and Competitors
Table 86. Teva Peptide and Anticoagulant Drugs Major Business
Table 87. Teva Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Teva SWOT Analysis
Table 89. Teva Peptide and Anticoagulant Drugs Product and Services
Table 90. Teva Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Aspen Basic Information, Manufacturing Base and Competitors
Table 92. Aspen Peptide and Anticoagulant Drugs Major Business
Table 93. Aspen Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Aspen SWOT Analysis
Table 95. Aspen Peptide and Anticoagulant Drugs Product and Services
Table 96. Aspen Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 98. Novo Nordisk Peptide and Anticoagulant Drugs Major Business
Table 99. Novo Nordisk Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 100. Novo Nordisk SWOT Analysis
Table 101. Novo Nordisk Peptide and Anticoagulant Drugs Product and Services
Table 102. Novo Nordisk Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Takeda Basic Information, Manufacturing Base and Competitors
Table 104. Takeda Peptide and Anticoagulant Drugs Major Business
Table 105. Takeda Peptide and Anticoagulant Drugs Total Revenue (USD Million) (2017-2018)
Table 106. Takeda SWOT Analysis
Table 107. Takeda Peptide and Anticoagulant Drugs Product and Services
Table 108. Takeda Peptide and Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global Peptide and Anticoagulant Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 110. Global Peptide and Anticoagulant Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global Peptide and Anticoagulant Drugs Sales by Regions (2015-2020) (K Units)
Table 112. Global Peptide and Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 113. Global Peptide and Anticoagulant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 114. North America Peptide and Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 115. North America Peptide and Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 116. North America Peptide and Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 117. North America Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 118. Europe Peptide and Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 119. Europe Peptide and Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 120. Europe Peptide and Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific Peptide and Anticoagulant Drugs Sales by Regions (2015-2020) (K Units)
Table 122. Asia-Pacific Peptide and Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific Peptide and Anticoagulant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 124. South America Peptide and Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 125. South America Peptide and Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 126. South America Peptide and Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 127. South America Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa Peptide and Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 129. Middle East & Africa Peptide and Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa Peptide and Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 132. Global Peptide and Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 133. Global Peptide and Anticoagulant Drugs Sales Share by Type (2015-2020)
Table 134. Global Peptide and Anticoagulant Drugs Revenue by Type (2015-2020) (USD Million)
Table 135. Global Peptide and Anticoagulant Drugs Revenue Share by Type (2015-2020)
Table 136. Global Peptide and Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 137. Global Peptide and Anticoagulant Drugs Sales Share by Application (2015-2020)
Table 138. Global Peptide and Anticoagulant Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 139. Global Peptide and Anticoagulant Drugs Market Share Forecast by Regions (2021-2025)
Table 140. Global Peptide and Anticoagulant Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 141. Global Peptide and Anticoagulant Drugs Market Share Forecast by Type (2021-2025)
Table 142. Global Peptide and Anticoagulant Drugs Sales Forecast by Application (2021-2025)
Table 143. Global Peptide and Anticoagulant Drugs Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Peptide and Anticoagulant Drugs Picture
Figure 2. Global Sales Market Share of Peptide and Anticoagulant Drugs by Type in 2019
Figure 3. Hormonal Picture
Figure 4. Antibiotic Picture
Figure 5. ACE Inhibitor Picture
Figure 6. Antifungal Picture
Figure 7. Others Picture
Figure 8. Peptide and Anticoagulant Drugs Sales Market Share by Application in 2018
Figure 9. Diabetes Picture
Figure 10. Infectious Diseases Picture
Figure 11. Cancer Picture
Figure 12. Osteoporosis Picture
Figure 13. Cardiology Picture
Figure 14. Gynecology Picture
Figure 15. Other Applications Picture
Figure 16. Global Peptide and Anticoagulant Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Peptide and Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Peptide and Anticoagulant Drugs Sales Market Share by Manufacturer in 2019
Figure 37. Global Peptide and Anticoagulant Drugs Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Peptide and Anticoagulant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Peptide and Anticoagulant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 42. Global Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Peptide and Anticoagulant Drugs Revenue Market Share by Regions (2015-2020)
Figure 44. Global Peptide and Anticoagulant Drugs Revenue Market Share by Regions in 2018
Figure 45. North America Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 46. Europe Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 48. South America Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 50. North America Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Peptide and Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Figure 52. North America Peptide and Anticoagulant Drugs Sales Market Share by Countries in 2018
Figure 53. North America Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Peptide and Anticoagulant Drugs Revenue Market Share by Countries in 2018
Figure 55. United States Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Canada Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Mexico Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Europe Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Peptide and Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 61. Germany Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. UK Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. France Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Russia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Italy Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Asia-Pacific Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Peptide and Anticoagulant Drugs Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Peptide and Anticoagulant Drugs Revenue Market Share by Regions 2019
Figure 69. China Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Japan Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Korea Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. India Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Southeast Asia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. South America Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Peptide and Anticoagulant Drugs Sales Market Share by Countries in 2019
Figure 76. South America Peptide and Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 77. Brazil Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Argentina Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Middle East and Africa Peptide and Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Peptide and Anticoagulant Drugs Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Peptide and Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Peptide and Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Egypt Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Turkey Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 86. South Africa Peptide and Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Global Peptide and Anticoagulant Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 88. Global Peptide and Anticoagulant Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Peptide and Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Europe Sales Peptide and Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Asia-Pacific Sales Peptide and Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 92. South America Sales Peptide and Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 93. Middle East & Africa Sales Peptide and Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
経口抗凝固剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Anticoagulant market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Anticoagulant market …- 無菌注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sterile Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4258.5 million by 2025, from USD 3506.7 million in 2019. The Sterile Inj…
- ナトリウム利尿ペプチドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Natriuretic Peptide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Natriuretic Peptide marke…
- ペプチド核酸の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptide Nucleic Acid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptide Nucleic Acid mar…
- マリンボーンコラーゲンペプチドパウダーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Marine Bone Collagen Peptide Powder market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Marine Bo…